IL-22 induces an acute-phase response.

Liang, Spencer C; Nickerson-Nutter, Cheryl; Pittman, Debra D; Carrier, Yijun; Goodwin, Debra G; Shields, Kathleen M; Lambert, Andre-Jean; Schelling, Scott H; Medley, Quintus G; Ma, Hak-Ling; Collins, Mary; Dunussi-Joannopoulos, Kyriaki; Fouser, Lynette A

Liang, Spencer C; Nickerson-Nutter, Cheryl; Pittman, Debra D; Carrier, Yijun; Goodwin, Debra G; Shields, Kathleen M; Lambert, Andre-Jean; Schelling, Scott H; Medley, Quintus G; Ma, Hak-Ling; Collins, Mary; Dunussi-Joannopoulos, Kyriaki; Fouser, Lynette A.

Liang SC; Inflammation and Immunology Research Unit, Pfizer Biotherapeutics Research and Development, Cambridge, MA 02140, USA.

J Immunol ; 185(9): 5531-8, 2010 Nov 01.

Article en En | MEDLINE | ID: mdl-20870942

Asunto(s)

Reacción de Fase Aguda/inmunología; Reacción de Fase Aguda/fisiopatología; Interleucinas/inmunología; Animales; Ratones; Ratones Endogámicos C57BL; Ratones Noqueados; Interleucina-22

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Interleucinas / Reacción de Fase Aguda Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2010 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google